Literature DB >> 23482787

Tumor necrosis in patients with TNM stage IV colorectal cancer without residual disease (R0 Status) is associated with a poor prognosis.

Koji Komori1, Yukihide Kanemitsu, Kenya Kimura, Norifumi Hattori, Tsuyoshi Sano, Seiji Ito, Tetsuya Abe, Yoshiki Senda, Kazunari Misawa, Yuichi Ito, Norihisa Uemura, Yasuhiro Shimizu.   

Abstract

AIM: To examine the usefulness of the histopathological finding of tumor necrosis for stratifying TNM stage IV colorectal cancer in R0 status. PATIENTS AND METHODS: We enrolled 98 patients with stage IV colorectal cancer, without residual disease after resection. The extent of necrosis was assessed using published thresholds, the extent was graded as "absent", "moderate" (<30% of tumor area), or "severe" (≥30%) in each section.
RESULTS: In multivariate analysis, the only significant difference in the disease-free survival rate was related to tumor necrosis (p=0.01) and the significant differences in the overall survival rates were related to the maximum tumor size and the degree of tumor necrosis (p=0.02 and p=0.001, respectively).
CONCLUSION: Tumor necrosis is associated with a poor prognosis in colorectal cancer and may allow the stratification of TNM stage IV patients without residual disease after surgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23482787

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Histopathologic risk stratification of stage IIB colorectal cancer.

Authors:  Koji Komori; Takashi Kinoshita; Taihei Oshiro; Seiji Ito; Tetsuya Abe; Yoshiki Senda; Kazunari Misawa; Yuichi Ito; Norihisa Uemura; Seiji Natsume; Jiro Kawakami; Akira Ouchi; Masayuki Tsutsuyama; Takahiro Hosoi; Itaru Shigeyoshi; Tomoyuk Akazawa; Daisuke Hayashi; Hideharu Tanaka; Yasuhiro Shimizu
Journal:  Surg Today       Date:  2016-12-30       Impact factor: 2.549

2.  T cell stemness and dysfunction in tumors are triggered by a common mechanism.

Authors:  Suman Kumar Vodnala; Robert Eil; Rigel J Kishton; Madhusudhanan Sukumar; Tori N Yamamoto; Ngoc-Han Ha; Ping-Hsien Lee; MinHwa Shin; Shashank J Patel; Zhiya Yu; Douglas C Palmer; Michael J Kruhlak; Xiaojing Liu; Jason W Locasale; Jing Huang; Rahul Roychoudhuri; Toren Finkel; Christopher A Klebanoff; Nicholas P Restifo
Journal:  Science       Date:  2019-03-29       Impact factor: 47.728

Review 3.  Prognostic stratification of colorectal cancer patients: current perspectives.

Authors:  Nora I Schneider; Cord Langner
Journal:  Cancer Manag Res       Date:  2014-07-02       Impact factor: 3.989

4.  DNA methylation combinations in adjacent normal colon tissue predict cancer recurrence: evidence from a clinical cohort study.

Authors:  Jen Chun Kuan; Chang Chieh Wu; Chien An Sun; Chi Ming Chu; Fu Gong Lin; Chih Hsiung Hsu; Po-Chieh Kan; Shih-Chieh Lin; Tsan Yang; Yu-Ching Chou
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

5.  Epidermal growth factor receptor-targeted molecular imaging of colorectal tumors: Detection and treatment evaluation of tumors in animal models.

Authors:  Yoshihiko Miyamoto; Naoki Muguruma; Shota Fujimoto; Yasuyuki Okada; Yoshifumi Kida; Fumika Nakamura; Kumiko Tanaka; Tadahiko Nakagawa; Shinji Kitamura; Koichi Okamoto; Hiroshi Miyamoto; Yasushi Sato; Tetsuji Takayama
Journal:  Cancer Sci       Date:  2019-05-20       Impact factor: 6.716

6.  BZD9L1 sirtuin inhibitor as a potential adjuvant for sensitization of colorectal cancer cells to 5-fluorouracil.

Authors:  Yi Jer Tan; Yeuan Ting Lee; Sven H Petersen; Gurjeet Kaur; Koji Kono; Soo Choon Tan; Amin M S Abdul Majid; Chern Ein Oon
Journal:  Ther Adv Med Oncol       Date:  2019-09-27       Impact factor: 8.168

7.  Neutrophil infiltration combined with necrosis in the primary tumor is a useful prognostic indicator for three-year disease-free survival time in patients with colorectal cancer.

Authors:  Katarzyna Jakubowska; Mariusz Koda; Małgorzata Grudzińska; Wojciech Kisielewski; Karolina Lomperta; Waldemar Famulski
Journal:  Oncol Lett       Date:  2022-05-06       Impact factor: 2.967

8.  Systemic inflammation is associated with circulating cell death released keratin 18 fragments in colorectal cancer.

Authors:  Päivi Sirniö; Juha P Väyrynen; Shivaprakash J Mutt; Karl-Heinz Herzig; Jaroslaw Walkowiak; Kai Klintrup; Jyrki Mäkelä; Tuomo J Karttunen; Markus J Mäkinen; Anne Tuomisto
Journal:  Oncoimmunology       Date:  2020-06-24       Impact factor: 8.110

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.